AP
Aprea Therapeutics, Inc.
APRE · NASDAQ
$0.73 +0.21% (+$0.00)
1M +8.71%
Market Cap $9.05M
P/E Ratio -
Div. Yield -
ROE 46.72%
Bulios Fair Price
$1.07
46.5% upside
Trenutna cena
$0.73
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica APRE trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.24x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 21.42%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 33.73%
ROE 46.72%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 13.55x
Int. coverage N/A
Stability
29 /100
Unstable Beta 1.63x
EPS volatility 42.26%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o APRE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Oren Gilad
Employees
8
Headquarters
Boston
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report